Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A carbapenem (most often imipenem) was found in a prospective observational study to be the optimal choice for therapy of bacteremia due to ESBL-producing <I>Klebsiella pneumoniae</I>.

Treatment of Bacteremia Due to ESBL-Producing Klebsiella pneumoniae